Your browser doesn't support javascript.
loading
A nationwide prospective cohort study on safety of the 17D-204 yellow fever vaccine during a vaccine shortage in Japan.
Miyazato, Yusuke; Terada, Mari; Ujiie, Mugen; Saito, Sho; Moriya, Akinari; Ando, Masao; Ohmagari, Norio.
Afiliação
  • Miyazato Y; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Terada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Ujiie M; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
  • Moriya A; Division of Quarantine and Sanitation, Chubu Airport Quarantine Office, Nagoya Quarantine Station, Nagoya 479-0881, Japan.
  • Ando M; Sendai Quarantine Station, Sendai 985-0011, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku, Tokyo 162-8655, Japan.
J Travel Med ; 30(2)2023 04 05.
Article em En | MEDLINE | ID: mdl-35640301
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Amarela / Vacinas / Vacina contra Febre Amarela Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Febre Amarela / Vacinas / Vacina contra Febre Amarela Idioma: En Ano de publicação: 2023 Tipo de documento: Article